⌘K

Login Start Free

Home/Filings/4/0000899243-20-015328

4//SEC Filing

Thierer Mark 4

Accession 0000899243-20-015328

CIK 0001346302other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 9:02 PM ET

Size

5.3 KB

Accession

0000899243-20-015328

Insider Transaction Report

Form 4

Period: 2020-06-04

XERIS PHARMACEUTICALS INCXERS

Director

Transactions

Award
Stock Option (right to buy)
2020-06-04+11,228→ 11,228 total
Exercise: $4.68Exp: 2030-06-04→ Common Stock (11,228 underlying)

Footnotes (1)

[F1]Such options will vest in full upon the earlier to occur of June 4, 2021 or the date of the Company's next annual meeting of stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

XERIS PHARMACEUTICALS INC

CIK 0001346302

Entity typeother

Related Parties

1

filerCIK 0001334925

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 9:02 PM ET
Size: 5.3 KB

View on SEC.gov